Epigenomics, epigenetics, and cancer

Michel Lopes Leite; Fabricio F. Costa

doi:10.5123/S2176-62232017000400006

Autores/as

Michel Lopes Leite Universidade Católica de Brasília, Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Brasília, Distrito Federal, Brasil
Fabricio F. Costa Universidade Católica de Brasília, Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Brasília, Distrito Federal, Brasil. Northwestern University, Feinberg School of Medicine, Cancer Biology and Epigenomics Program, Chicago, Illinois, USA. Genomic Enterprise, Chicago, Illinois, USA. Genome Connect, Chicago, Illinois, USA. MATTER Chicago, Chicago, Illinois, USA. The Founder Institute, San Francisco, California, USA

DOI:

https://doi.org/10.5123/S2176-62232017000400006

Resumen

Opinion article written by Speaker for the II International Scientific Meeting of Instituto Evandro Chagas, held from October 25 to 27, 2017, in Ananindeua, Pará, Brazil. All the articles of this modality were analyzed by the Scientific Committee of the Event and, later, by the Editors of RPAS.